DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2–infected individuals interact with Fc receptor–expressing cells but do not neutralize the virus
The membrane (M) glycoprotein of SARS-CoV-2 is one of the key viral proteins regulating virion assembly and morphogenesis. Immunologically, the M protein is a major source of peptide antigens driving T cell responses, and most individuals who have been infected with SARS-CoV-2 make antibodies to the N-terminal, surface-exposed peptide of the M protein. We now report that although the M protein is abundant in the viral particle, antibodies to the surface-exposed N-terminal epitope of M do not appear to neutralize the virus. M protein–specific antibodies do, however, activate antibody-dependent cell-mediated cytotoxicity and cytokine secretion by primary human natural killer cells. Interestingly, while patients with severe or mild disease make comparable levels of M antigen–binding antibodies, M-specific antibodies from the serum of critically ill patients are significantly more potent activators of antibody-dependent cell-mediated cytotoxicity than antibodies found in individuals with mild or asymptomatic infection., This work was supported by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028) and grants from Comunidad de Madrid (IMMUNOTHERCAN, S2017/BMD-3733-2 [M.V.-G.]), the Spanish Ministry of Science and Innovation (MCIN)/Spanish Research Agency (AEI) (MCIN/AEI/FEDER, EU: RTI2018-093569-B-I00, PID 2021-123795OB-I00 [both to M.V.-G.] and PID2020-115506RB-I00 [H.T.R.]). This research work was also funded by the European Commission—NextGenerationEU (Regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI Salud Global). The Centro Nacional de Biotecnología also receives financial support from the Spanish State Research Agency (AEI/10.13039/501100011033) through the Severo Ochoa Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712). D.F.S. is a recipient of a fellowship (PRE2018-083200) from the Spanish Ministry of Science and Innovation., Peer reviewed
Project:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 RTI2018-093569-B-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-123795OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-115506RB-I00
,
AEI PRE2018-083200
View at: http://hdl.handle.net/10261/350460